These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 32740733

  • 1. Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation.
    Dee EC, Freret ME, Horick N, Raldow AC, Goyal L, Zhu AX, Parikh AR, Ryan DP, Clark JW, Allen JN, Ferrone CR, Fernandez-Del Castillo C, Tanabe KK, Drapek LC, Hong TS, Qadan M, Wo JY.
    Ann Surg Oncol; 2020 Dec; 27(13):5161-5172. PubMed ID: 32740733
    [Abstract] [Full Text] [Related]

  • 2. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS, Zhang Q, Sada YH, Chai C, Curley SA, Massarweh NN.
    Cancer; 2018 Jan 01; 124(1):74-83. PubMed ID: 28841223
    [Abstract] [Full Text] [Related]

  • 3. Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas.
    Fareed MM, DeMora L, Esnaola NF, Denlinger CS, Karachristos A, Ross EE, Hoffman J, Meyer JE.
    J Gastrointest Oncol; 2018 Aug 01; 9(4):762-768. PubMed ID: 30151273
    [Abstract] [Full Text] [Related]

  • 4. Predictors of Locoregional Failure and Impact on Overall Survival in Patients With Resected Exocrine Pancreatic Cancer.
    Merrell KW, Haddock MG, Quevedo JF, Harmsen WS, Kendrick ML, Miller RC, Hallemeier CL.
    Int J Radiat Oncol Biol Phys; 2016 Mar 01; 94(3):561-70. PubMed ID: 26867884
    [Abstract] [Full Text] [Related]

  • 5. Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers.
    Rhodin KE, Liu A, Bartholomew A, Kramer R, Parameswaran A, Uronis H, Strickler J, Hsu D, Morse MA, Shah KN, Herbert G, Zani S, Nussbaum DP, Allen PJ, Lidsky ME.
    Ann Surg Oncol; 2023 Aug 01; 30(8):4813-4821. PubMed ID: 37188803
    [Abstract] [Full Text] [Related]

  • 6. Current standards and future perspectives in adjuvant treatment for biliary tract cancers.
    Lamarca A, Edeline J, McNamara MG, Hubner RA, Nagino M, Bridgewater J, Primrose J, Valle JW.
    Cancer Treat Rev; 2020 Mar 01; 84():101936. PubMed ID: 31986437
    [Abstract] [Full Text] [Related]

  • 7. Outcome of adjuvant therapy in biliary tract cancers.
    McNamara MG, Walter T, Horgan AM, Amir E, Cleary S, McKeever EL, Min T, Wallace E, Hedley D, Krzyzanowska M, Moore M, Gallinger S, Greig P, Serra S, Dawson LA, Knox JJ.
    Am J Clin Oncol; 2015 Aug 01; 38(4):382-7. PubMed ID: 24572429
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
    Kim H, Heo MH, Kim JY.
    BMC Gastroenterol; 2020 Jan 28; 20(1):20. PubMed ID: 31992208
    [Abstract] [Full Text] [Related]

  • 9. Meta-analysis of randomized clinical trials of adjuvant chemotherapy for resected biliary tract cancers.
    Ma WJ, Jin YW, Wu ZR, Yang Q, Wang JK, Liu F, Shi YJ, Li QS, Cheng NS.
    HPB (Oxford); 2020 Jul 28; 22(7):939-949. PubMed ID: 32349925
    [Abstract] [Full Text] [Related]

  • 10. The efficacy and safety of 5-fluorouracil based adjuvant therapy in resected biliary tract cancer: A systematic review and meta-analysis.
    Song S, Yang W, Tian H, Gong S, Lei C, Lv K, Lu T, Cheng Q, Yang K, Guo T.
    Clin Res Hepatol Gastroenterol; 2022 Feb 28; 46(2):101788. PubMed ID: 34389530
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium.
    Krasnick BA, Jin LX, Davidson JT, Sanford DE, Ethun CG, Pawlik TM, Poultsides GA, Tran T, Idrees K, Hawkins WG, Chapman WC, Doyle MBM, Weber SM, Strasberg SM, Salem A, Martin RCG, Isom CA, Scoggins C, Schmidt CR, Shen P, Beal E, Hatzaras I, Shenoy R, Maithel SK, Fields RC.
    J Surg Oncol; 2018 Mar 28; 117(3):363-371. PubMed ID: 29284072
    [Abstract] [Full Text] [Related]

  • 12. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS, Hwang IG, Park SE, Go SI, Kang JH, Park I, Oh SY, Ji JH, Song HN, Park SH, Kim ST, Park JO.
    Cancer Chemother Pharmacol; 2016 May 28; 77(5):979-85. PubMed ID: 27017615
    [Abstract] [Full Text] [Related]

  • 13. Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer.
    Kim TH, Han SS, Park SJ, Lee WJ, Woo SM, Moon SH, Yoo T, Kim SS, Kim SH, Hong EK, Kim DY, Park JW.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):e853-9. PubMed ID: 21497455
    [Abstract] [Full Text] [Related]

  • 14. Outcomes in biliary malignancy.
    Groot Koerkamp B, Fong Y.
    J Surg Oncol; 2014 Oct 01; 110(5):585-91. PubMed ID: 25250887
    [Abstract] [Full Text] [Related]

  • 15. Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium.
    Toyoda J, Sahara K, Maithel SK, Abbott DE, Poultsides GA, Wolfgang C, Fields RC, He J, Scoggins C, Idrees K, Shen P, Endo I, Pawlik TM.
    Ann Surg Oncol; 2022 Nov 01; 29(12):7605-7614. PubMed ID: 35768667
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database.
    Zhu Y, Liu X, Lin Y, Tang L, Yi X, Xu H, Yuan Y, Chen Y.
    Eur J Med Res; 2023 Sep 01; 28(1):310. PubMed ID: 37658421
    [Abstract] [Full Text] [Related]

  • 17. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
    Abrams RA, Grochow LB, Chakravarthy A, Sohn TA, Zahurak ML, Haulk TL, Ord S, Hruban RH, Lillemoe KD, Pitt HA, Cameron JL, Yeo CJ.
    Int J Radiat Oncol Biol Phys; 1999 Jul 15; 44(5):1039-46. PubMed ID: 10421536
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study.
    Lim KH, Oh DY, Chie EK, Jang JY, Im SA, Kim TY, Kim SW, Ha SW, Bang YJ.
    BMC Cancer; 2009 Sep 27; 9():345. PubMed ID: 19781103
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.